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2017 Hospital Profile
Overview / Size Payer Mix
Hospital System Affiliation: Public Payer Mix:
Change in Ownership (FY13-17): CY16 Commercial Statewide Relative Price:
Total Staffed Beds: Top 3 Commercial Payers:
% Occupancy:
Special Public Funding:
Change FY16-FY17:
Financial Emergency Department Visits in FY17:
Inpatient NPSR per CMAD: Change FY16-FY17:
Outpatient Visits in FY17:
For descriptions of the metrics, please see the technical appendix.
CHART^, ICB°
Trauma Center Designation: Not Applicable
Case Mix Index:
Blue Cross Blue Shield of Massachusetts
Harvard Pilgrim Health Care
Tufts Associated HMO, Inc.
Change FY16-FY17: 1.9% 509,586
Inpatient:Outpatient Revenue in FY17:
63.3% (HPP* Hospital)
-2.4%
Utilization
0.91, < cohort avg. (0.92); < statewide (1.12)
Inpatient Discharges in FY17:
Wellforce
46,823
Wellforce - 2017 0.90
166, mid-size acute hospital
90.8%, > cohort avg. (66%)
10,992
-3.9%
28%:72% Change FY16-FY17: -4.8%
$9,725
MELROSEWAKEFIELD HOSPITAL
Medford & Melrose, MA
Community High Public Payer Hospital
Metro Boston
MelroseWakefield Healthcare System, which includes Lawrence Memorial Hospital and Melrose-Wakefield Hospital campuses, is a mid-size, non-profit 
community High Public Payer (HPP) hospital system located in the Metro Boston region. Between FY13 and FY17, their inpatient discharges decreased 
by 11.8%, compared to a median increase of 1.1% among their peer cohort hospitals. MelroseWakefield Healthcare reported a profit of $7.9M in FY17, 
after posting a loss of $1.9M in FY16. It had reported profits in each of the three prior years from FY13 to FY15. MelroseWakefield Healthcare changed its 
name from Hallmark Health System in May of 2018.
Change FY12-FY16 (percentage points):
Outpatient Revenue in FY17: $144,261,248
Quality
Early Elective Deliveries Rate: 0.0%
What proportion of adult patient discharges from this hospital resulted 
in a readmission at any hospital within 30 days, and how does this 
compare to the state average?
How many central line-associated blood stream infections (CLABSI), 
catheter-associated urinary tract infections (CAUTI), and surgical site 
infections (SSI) after colon surgery did patients get at this hospital 
compared to what was expected based on the hospital's characteristics 
and case mix?
17.6%
Total Revenue in FY17: $272,842,000
0.1
Total Surplus (Loss) in FY17: $7,864,000
Change FY16-FY17: 0.7%
Readmission Rate in FY16:
What were the most common inpatient cases (DRGs) treated at the 
hospital in FY17? What proportion of the region’s cases did this 
hospital treat for each service? 
Where did most of the hospital's inpatients reside? What proportion of 
each community's total discharges was attributed to this hospital?
 - - - Hospital  (10,992) = 4%  of total regional  discharges 
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Renal Failure (259)
Cesarean Delivery (273)
Cardiac Arrhythmia   (294)
Septicemia Infections (416)
COPD (534)
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Vaginal Delivery (600)
Normal Neonate Birth (805)
Discharges by DRG 
of regional 
discharges 
were treated 
at this hospital 
in FY17 
 
9% 
2% 
10% 
8% 
20% 
30% 
29% 
39% 
25% 
27% 
0% 20% 40% 60% 80% 100%
Reading MA (220)
Lynn MA (223)
Everett MA (496)
Revere MA (517)
Stoneham MA (596)
Wakefield MA (872)
Saugus MA (1,011)
Melrose MA (1,170)
Medford MA (1,498)
Malden MA (1,741)
Discharges by Community 
Q
u
al
it
y 17.5% 17.6% 
 
 15.4% 15.4% 
0%
5%
10%
15%
20%
25%
2012 2016
State Average 
0
1
2
3
4
5
Lower is Better  
CLABSI 
 
CAUTI SSI: Colon Surgery 
    
of community 
discharges 
were treated at 
this hospital in 
FY17 
Lower is Better  
A
t 
a 
G
la
n
ce
 
S
er
vi
ce
s 
A44
Key:
Hospital
Cohort: Community High Public Payer Hospital Peer Cohort
For descriptions of the metrics, please see the technical appendix.
* High Public Payer Hospitals (HPP) receive a minimum of 63% of gross patient service revenue from public payers.
^ For more information on Community Hospital Acceleration, Revitalization and Transformation (CHART) special funding, please contact the Health Policy Commission (HPC).
° For more information on Infrastructure and Capacity Building (ICB) special funding, please contact the Massachusetts Executive Office of Health and Human Services (EOHHS).
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2017 HOSPITAL PROFILE: MELROSEWAKEFIELD HOSPITAL
How has the volume of the hospital's inpatient discharges changed 
compared to FY13, and how does this compare to the hospital's peer 
cohort median? (FY13=100)
How has the volume of the hospital's outpatient visits changed 
compared to FY13, and how does this compare to the hospital's peer 
cohort median? (FY13=100)
What was the hospital's net inpatient service revenue per case mix 
adjusted discharge between FY13 and FY17, and how does this 
compare to the hospital's peer cohort median?
How has the hospital's total outpatient revenue changed compared to 
FY13, and how does this compare to the hospital's peer cohort 
median? (FY13=100)
How have the hospital's total revenue and costs changed between 
FY13 and FY17?
What were the hospital's total margin and operating margins between 
FY13 and FY17, and how do these compare to the hospital's peer 
cohort medians?
Revenue, Cost, & Profit/Loss (in millions)
FY 2013 2014 2015 2016
11.6$     
 Operating Revenue 263.6$   257.0$   262.4$   257.7$   261.2$   
Non-Operating 
Revenue
8.0$       9.2$       9.0$       7.7$       
265.0$   
Total Revenue 271.6$   266.3$   271.4$   265.4$   272.8$   
Total Costs 258.8$   252.8$   258.4$   267.3$   
Total Profit (Loss) 12.8$     13.5$     13.0$     (1.9)$     7.9$       
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